Epigenetic fragility of the endocannabinoid system under stress: Risk for mood disorders and pharmacogenomic implications

Sari Goldstein Ferber; Tania L. Roth; Aron Weller

doi:10.2217/epi-2020-0037

Epigenetic fragility of the endocannabinoid system under stress: Risk for mood disorders and pharmacogenomic implications

Sari Goldstein Ferber, Tania L. Roth, Aron Weller

Department of Psychology

Research output: Contribution to journal › Review article › peer-review

5 Scopus citations

Original language	English
Pages (from-to)	657-660
Number of pages	4
Journal	Epigenomics
Volume	12
Issue number	8
DOIs	https://doi.org/10.2217/epi-2020-0037
State	Published - Apr 2020

Bibliographical note

Funding Information:
Research in AW’s lab is partially funded by the Israel Science Foundation, The Israel Ministry of Science and EPM, Inc. Research in TLR’s lab is funded by Grant 1R01HD087509 from the National Institute of Child Health and Human Development. These funding sources did not have any input in the content of this manuscript. Beyond the above, the authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No writing assistance was utilized in the production of this manuscript.

Funding

Research in AW’s lab is partially funded by the Israel Science Foundation, The Israel Ministry of Science and EPM, Inc. Research in TLR’s lab is funded by Grant 1R01HD087509 from the National Institute of Child Health and Human Development. These funding sources did not have any input in the content of this manuscript. Beyond the above, the authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No writing assistance was utilized in the production of this manuscript.

Funders	Funder number
EPM, Inc.	1R01HD087509
Israel Ministry of Science
National Institute of Child Health and Human Development
Israel Science Foundation

Keywords

2-AG
CB1
FAAH
anxiety
depression
endocannabinoid System
pharmacogenomics
predisposition

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2217/epi-2020-0037

Cite this

@article{d54fe56cd588447d8618990738819014,

title = "Epigenetic fragility of the endocannabinoid system under stress: Risk for mood disorders and pharmacogenomic implications",

keywords = "2-AG, CB1, FAAH, anxiety, depression, endocannabinoid System, pharmacogenomics, predisposition",

author = "Ferber, {Sari Goldstein} and Roth, {Tania L.} and Aron Weller",

note = "Funding Information: Research in AW{\textquoteright}s lab is partially funded by the Israel Science Foundation, The Israel Ministry of Science and EPM, Inc. Research in TLR{\textquoteright}s lab is funded by Grant 1R01HD087509 from the National Institute of Child Health and Human Development. These funding sources did not have any input in the content of this manuscript. Beyond the above, the authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No writing assistance was utilized in the production of this manuscript.",

year = "2020",

month = apr,

doi = "10.2217/epi-2020-0037",

language = "אנגלית",

volume = "12",

pages = "657--660",

journal = "Epigenomics",

issn = "1750-1911",

publisher = "Future Medicine Ltd.",

number = "8",

}

TY - JOUR

T1 - Epigenetic fragility of the endocannabinoid system under stress

T2 - Risk for mood disorders and pharmacogenomic implications

AU - Ferber, Sari Goldstein

AU - Roth, Tania L.

AU - Weller, Aron

N1 - Funding Information: Research in AW’s lab is partially funded by the Israel Science Foundation, The Israel Ministry of Science and EPM, Inc. Research in TLR’s lab is funded by Grant 1R01HD087509 from the National Institute of Child Health and Human Development. These funding sources did not have any input in the content of this manuscript. Beyond the above, the authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No writing assistance was utilized in the production of this manuscript.

PY - 2020/4

Y1 - 2020/4

KW - 2-AG

KW - CB1

KW - FAAH

KW - anxiety

KW - depression

KW - endocannabinoid System

KW - pharmacogenomics

KW - predisposition

UR - http://www.scopus.com/inward/record.url?scp=85088205068&partnerID=8YFLogxK

U2 - 10.2217/epi-2020-0037

DO - 10.2217/epi-2020-0037

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???

C2 - 32396405

SN - 1750-1911

VL - 12

SP - 657

EP - 660

JO - Epigenomics

JF - Epigenomics

IS - 8

ER -

Epigenetic fragility of the endocannabinoid system under stress: Risk for mood disorders and pharmacogenomic implications

Bibliographical note

Funding

Keywords

UN SDGs

Access to Document

Other files and links

Cite this